Results 1 to 10 of about 634,930 (347)

In patients with suspected thrombotic thrombocytopenic purpura, what is the optimal time to therapeutic plasma exchange? [PDF]

Hematology, Transfusion and Cell Therapy
Background: In patients with suspected immune thrombotic thrombocytopenic purpura, guidelines suggest that therapeutic plasma exchange should be initiated within eight hours. However, this time threshold may be difficult to attain.
Alexandre Soares Ferreira Junior, Kate Sanborn, Morgana Pinheiro Maux Lessa, Alexander Gordee, Maragatha Kuchibhatla, Allison O. Taylor, Matthew S. Karafin, Oluwatoyosi A. Onwuemene   +7 more
doaj   +2 more sources

Therapeutic plasma exchange in amatoxin associated acute liver failure-results from the multi-center Amanita-PEX study. [PDF]

Crit Care
Stahl K, Nalbant B, Pape T, Breteau I, Coirier V, Cardoso FS, de Haan J, Janik MK, Wasmuth JC, Madaleno J, Merle U, Frohme J, Tepasse PR, Müller M, Große K, Linke A, Mareljic N, Larsen FS, Dahlqvist G, Kolev M, Schulze M, Willuweit K, Janke-Maier P, Dondorf F, Fierro-Angulo ÓM, Geerts A, Toapanta D, Dejean C, Alharthi M, Reverter E, Schenk H, Raevens S, Macías-Rodríguez RU, Rauchfuß F, Berg CP, Schmidt H, Geier A, Semmo N, Lanthier N, Bjerring PN, Lange CM, Sterneck M, Bruns T, Schmid S, van de Loo D, Demir M, Boettler T, Borges C, Nattermann J, Wronka K, den Hoed CM, Marques HP, Artru F, Levesque E, Wedemeyer H, Campos-Murguia A, Taubert R, Amanita-PEX-study group.   +57 more
europepmc   +2 more sources

Plasma Exchange in Patients With Severe Coronavirus Disease 2019: A Single-Center Experience

Critical Care Explorations, 2021
IMPORTANCE:. Recent evidence suggests a multilevel inflammatory syndrome as a driving factor in some of the most severely ill coronavirus disease 2019 patients with overlapping features to other hyperinflammatory or autoimmune diseases. Therefore, plasma
Christian Nusshag, MD, Christian Morath, MD, Claudius Speer, MD, Florian Kaelble, MD, Martin Zeier, MD, Monica Boxberger, MD, Elisa Schulze-Schleithoff, MD, Mascha O. Fiedler, MD, Markus A. Weigand, MD, Uta Merle, MD   +9 more
doaj   +1 more source

Effect of plasma exchange on in-hospital mortality in patients with pulmonary hemorrhage secondary to antineutrophil cytoplasmic antibody-associated vasculitis: A propensity-matched analysis using a nationwide administrative database. [PDF]

PLoS ONE, 2018
Secondary pulmonary hemorrhage increases the risk of mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis (AAV); plasma exchange therapy may improve outcomes in these patients.
Eishi Uechi, Masato Okada, Kiyohide Fushimi   +2 more
doaj   +1 more source

Plasma Exchange for ANCA-Associated Vasculitis: An International Survey of Patient PreferencesPlain Language Summary

Kidney Medicine, 2023
Rationale & Objective: We sought to elicit patient preferences regarding the use of plasma exchange in antineutrophil cytoplasmic antibody-associated vasculitis (AAV) and its tradeoffs of risk of kidney failure and risk of serious infection.
David Collister, Mark Farrar, Lesha Farrar, Paul Brown, Michelle Booth, Tracy Firth, Alfred Mahr, Linan Zeng, Mark A. Little, Reem A. Mustafa, Lynn A. Fussner, Alexa Meara, Gordon Guyatt, David Jayne, Peter A. Merkel, Michael Walsh   +15 more
doaj   +1 more source

Plasma Exchange and Plasma Adsorption

JAPANES JOURNAL OF MEDICAL INSTRUMENTATION, 1992
T Agishi
openaire   +3 more sources

Case Report: High-dose immunoglobulins prior to plasma exchange in severe pulmonary renal syndrome

Frontiers in Immunology, 2023
Plasma exchange rapidly depletes pathogenic anti-neutrophil cytoplasmic autoantibodies (ANCAs) and is considered for induction therapy in severe ANCA-associated vasculitis.
Ann-Kathrin Schäfer, Sascha Dierks, Moritz Schnelle, Peter Korsten, Samy Hakroush, Björn Tampe   +5 more
doaj   +1 more source

Efficacy and safety of plasma exchange for Kawasaki disease with coronary artery dilatation

Renal Replacement Therapy, 2017
Background The treatment of Kawasaki disease is controversial when intravenous immunoglobulin therapy fails, although it typically relies on combinations of prednisolone, infliximab, cyclosporine, and plasma exchange therapy. The goal of the treatment is
Yusuke Kaida, Takatoshi Kambe, Shintaro Kishimoto, Yusuke Koteda, Kenji Suda, Ryo Yamamoto, Tetsurou Imai, Takuma Hazama, Yoshimi Takamiya, Ryo Shibata, Hidemi Nishida, Seiya Okuda, Kei Fukami   +12 more
doaj   +1 more source

TTP-like syndrome associated with hemoglobin SC disease treated successfully with plasma and red cell exchange

Leukemia Research Reports, 2019
Background: Sickle cell hemoglobinopathies are associated with end organ damage but very rarely present with a clinical and laboratory picture of microangiopathic hemolytic anemia (MAHA) and thrombocytopenia, characteristic of thrombotic microangiopathy (
Sreenath Kodali, Preethi Ramachandran, Ivan N. Richard, Jen-Chin Wang   +3 more
doaj   +1 more source

Therapeutic Plasma Exchange: For Cancer Patients

Cancer Management and Research, 2022
Yuru Hu, Hanshan Yang, Shaozhi Fu, Jingbo Wu Department of Oncology, The Affiliated Hospital of Southwest Medical University, Luzhou, 646000, People’s Republic of ChinaCorrespondence: Jingbo Wu; Shaozhi FuDepartment of Oncology, The Affiliated Hospital ...
Hu Y, Yang H, Fu S, Wu J
doaj